Titlesort ascending Credit Type Event date Cost
Understanding the Role of Lp(a) as a CV Risk Marker to Therapeutic Target in the Prevention of ASCVD
    • 1.50 CDE
    • 1.50 ACPE Pharmacy
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 ANCC
    • 1.50 Participation
 Enduring $0.00
The Risk Stratification and Treatment of Chronic Kidney Disease in Women: Uncovering and Addressing Disparities to Improve Outcomes
    • 1.00 ACPE Pharmacy
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
    • 1.00 Participation
 Enduring $0.00
The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis
    • 0.75 ACPE Pharmacy
    • 0.75 AMA PRA Category 1 Credit™
    • 0.75 ANCC
    • 0.75 Participation
 Enduring $0.00
The Burden of Resistant Hypertension in Women: Novel and Emerging Approaches to Improve Outcomes
    • 0.50 ACPE Pharmacy
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 ANCC
    • 0.50 Participation
 Enduring $0.00
Scratching the Surface of BTK Inhibition for Chronic Spontaneous Urticaria: Beyond Skin Deep
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
    • 1.00 Participation
 Enduring $0.00
Psoriasis in Skin of Color Unplugged: Addressing the Barriers to Patient Care and Relief
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
    • 1.00 Participation
 Enduring $0.00
Podcast - Ironing Out the Data: Iron Deficiency in Heart Failure
    • 0.50 ACPE Pharmacy
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 ANCC
    • 0.50 Participation
 Enduring $0.00
PAINWeek 2024 Digital All Access
    • 80.00 ACCME (MD/DO Only)
    • 80.00 AANP
      • 31.00 AANP Pharmacology Hours
    • 80.00 APA
    • 80.00 ACCME (All Other)
      • 38.00 MATE ACT credit
    • 80.00 ACPE Pharmacy
    • 80.00 ANCC
 Enduring $899.00
Optimizing the Recognition and Treatment of Chronic Kidney Disease in Patients with Type 2 Diabetes: What Primary Care Clinicians Need to Know
    • 1.25 ACPE Pharmacy
    • 1.25 AMA PRA Category 1 Credit™
    • 1.25 ANCC
    • 1.25 Participation
 Enduring $0.00
Exploring Novel Strategies for LDL-C Combination Therapy to Decrease ASCVD Risk: A Paradigm Shift
    • 1.50 CDE
    • 1.50 ACPE Pharmacy
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 ANCC
    • 1.50 Participation
 Enduring $0.00
Expanding the Therapeutic “AHR”senal for Pediatric Atopic Dermatitis
    • 1.00 AAPA Category I CME
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
    • 1.00 Participation
 Enduring $0.00
Escape Room Experience: Individualizing Treatment for Patients with Chronic Kidney Disease and Type 2 Diabetes
    • 1.00 ACPE Pharmacy
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
    • 1.00 Participation
 Enduring $0.00
Dietary Strategies for Reversing Type 2 Diabetes: Advances, Perspectives, and Expert Discussions
    • 4.00 Participation
 Enduring $0.00
Clinical Insights into Psoriasis in Patients of Color: Bringing New Data to Light
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
    • 1.00 Participation
 Enduring $0.00
Breaking Through Inertia: How to Initiate and Maintain Insulin Therapy in Patients with Type 2 Diabetes
    • 1.50 AAFP
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 Participation
 Enduring $0.00

Pages